Vacina de mRNA vacina se mostrou extremamente segura e efetiva contra COVID-19. Efeitos colaterais significativos na ordem de 1/1.000.000
Evasão a resposta imune ocorre naturalmente em qualquer plataforma, mas especificamente mRNA menos que as outras
Retrocesso e mistificação.
We reviewed the science, listened to the experts, and acted. BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu. We’re shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate.